n | %* | |
Sex | ||
Women | 8099 | 50.9 |
Men | 7023 | 49.1 |
Age group (years) | ||
18–34 | 2805 | 25.0 |
35–49 | 3553 | 22.7 |
50–64 | 4945 | 27.6 |
65–79 | 3126 | 18.4 |
80+ | 693 | 6.4 |
Education | ||
Low | 3267 | 31.0 |
Middle | 6326 | 41.9 |
High | 4916 | 27.1 |
Missing | 613 | – |
Income | ||
<60% of median | 1524 | 15.2 |
60%−<150% of median | 8406 | 57.6 |
≥150% of median | 5065 | 27.2 |
Missing | 127 | – |
Date of participation | ||
October 2020 | 5532 | (36.6) |
November 2020 | 6748 | (44.6) |
December 2020 | 2090 | (13.8) |
January 2021 | 595 | (3.9) |
February 2021 | 157 | (1.0) |
SARS-CoV-2 IgG antibodies | ||
Seropositive | 192 | 1.3 |
Seronegative | 14 589 | 98.7 |
Missing | 341 | – |
SARS-CoV-2 RNA | ||
PCR positive | 51 | 0.4 |
PCR negative | 14 638 | 99.6 |
Missing | 433 | – |
Previously tested positive for SARS-CoV-2† | ||
Yes | 146 | 1.1 |
No | 14 771 | 98.9 |
Missing | 205 | – |
*Weighted percentage (unweighted percentage in brackets).
†Self-reported positive throat swab test before study participation.